Medicaid Dominates U.S. Coverage for Novo Nordisk and Eli Lilly Weight-Loss Drugs
Government Programs Drive Access to GLP-1 Drugs State Medicaid programs and federal employee health plans are the leading sources of coverage for popular new weight-loss drugs,...